Big News:
FDA is moving from MasterControl to ComplianceQuest.
See Why
Search AgentQ
/
Talk to a Specialist
Loading…
My Dashboard
Inspection Tracker
Warning Letters
TXP Innovations LLC dba Tex Peptides
All Warning Letters
TXP Innovations LLC dba Tex Peptides
Warning Letter
Open
539 West Commerce Street Dallas , TX 75208-1953 United States
Issued Aug 24, 2026
Center for Drug Evaluation and Research (CDER)
Watch Company
View Letter
Source: FDA, published letter.
FDA published this warning letter; View Letter opens FDA's copy.
Violations
1
Issue Date
Aug 24, 2026
Product Type
Drugs
Status
Open
Overview
Violations
1
Related Form 483s
0
Related Inspections
0
Letter Details
Firm
TXP Innovations LLC dba Tex Peptides
Location
539 West Commerce Street Dallas , TX 75208-1953 United States
FEI Number
N/A
Country
United States
Issue Date
August 24, 2026
Issuing Office
Center for Drug Evaluation and Research (CDER)
Product Type
Drugs
Status
Open
Subject
Unapproved New Drugs/Misbranded
See the 1 Violation
TXP Innovations LLC dba Tex Peptides FDA Warning Letter, August 24, 2026
Talk to a SpecialistTalk to a SpecialistTalk to a Specialist